Premananda Allergy And Chest Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 19-12-2024
- Paid Up Capital ₹ 0.52 M
as on 19-12-2024
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.71 M
as on 19-12-2024
- Revenue -0.70%
(FY 2019)
- Profit -10.65%
(FY 2019)
- Ebitda 1.18%
(FY 2019)
- Net Worth 27.79%
(FY 2019)
- Total Assets 7.29%
(FY 2019)
About Premananda Allergy And Chest Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.52 M.
The company currently has active open charges totaling ₹1.71 M.
Raya Sudheer, Raya Madhavi, and Premanand Raya serve as directors at the Company.
- CIN/LLPIN
U85110AP1993PTC015892
- Company No.
015892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1993
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- LocationK.T.Road,Tirupathi,A.P., Andhra Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Premananda Allergy And Chest Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raya Madhavi  | Managing Director | 21-Jun-1993 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raya Sudheer | Director | 01-Jul-2005 | Current |
| Premanand Raya | Additional Director | 28-Feb-2015 | Current |
Financial Performance of Premananda Allergy And Chest Hospital.
Premananda Allergy And Chest Hospital Pvt Ltd, for the financial year ended 2019, experienced Minor drop in revenue, with a 0.7% decrease. The company also saw a substantial fall in profitability, with a 10.65% decrease in profit. The company's net worth Soared by an impressive increase of 27.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Premananda Allergy And Chest Hospital?
In 2019, Premananda Allergy And Chest Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 28 Jul 2000 | ₹0.45 M | Open |
A.P. State Financial Corporation Creation Date: 04 Feb 1994 | ₹1.26 M | Open |
How Many Employees Work at Premananda Allergy And Chest Hospital?
Unlock and access historical data on people associated with Premananda Allergy And Chest Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premananda Allergy And Chest Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premananda Allergy And Chest Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
